![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Corautus Enters Manufacturing Agreement With Boehringer Ingelheim
Corautus Enters Manufacturing Agreement With Boehringer Ingelheim
Corautus Genetics and Boehringer Ingelheim Austria GmbH announced that they have entered into a long term manufacturing agreement to produce VEGF-2 (Vascular Endothelial Growth Factor 2) plasmid DNA for a Phase III trial and future commercial use for the treatment of cardiovascular disease (severe angina) and other indications.
PharmaLive (http://www.pharmalive.com/News/index.cfm?articleid=239973&categoryid=21)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct